Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on June 2, 2025
Breakthrough Cancer Drug Makes Cancer Cells Collapse from Within — No Harm to Healthy Tissue
EIN Presswire
·
June 2, 2025
New drug triggers cancer cell self-destruction from the inside—obliterates tumors while leaving healthy tissue completely untouched. CAMBRIDGE, MA, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- In a revolutionary leap for cancer treatment, Boston- …
HEAG Expands Consulting Services to Include Student Account Services Support
EIN Presswire
·
June 2, 2025
New service helps colleges and universities improve student accounts operations with expert guidance in compliance, process improvement and financial practices. WELLESLEY, MA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- The Higher Education …
Quilt.AI Launches 'Social Meaning': A Revolutionary AI-Powered Platform Transforming Consumer Insights
EIN Presswire
·
June 2, 2025
BOSTON, MA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Quilt.AI, a cultural intelligence company, proudly announces the launch of Social Meaning, an innovative AI-driven analytics platform designed to decode the complexities of online consumer …
Access Fixtures Launches New and Improved Field Configurable Indoor Riding Arena Lighting Packages
EIN Presswire
·
June 2, 2025
Indoor riding arena lighting packages with selectable wattage and Kelvin, offering low glare, high performance, and durable, field-configurable fixtures. WORCESTER, MA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Access Fixtures, a leader in …
Harvard Bioscience Appoints John Duke to Board of Directors
GlobeNewswire
·
June 2, 2025
HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating …
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 23,820 restricted stock units (“RSUs”) to six newly-hired non-executive employees under the Company’s 2025 …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted three newly-hired employees options to purchase an …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on May 30, 2025, the company issued inducement awards to …
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on May 30, 2025, the company granted equity awards to four new employees, …
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates
GlobeNewswire
·
June 2, 2025
BOSTON and SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
PathMaker Neurosystems Announces Rhode Island Life Sciences Hub (RILSH) Funding to Establish Operations in Rhode Island
GlobeNewswire
·
June 2, 2025
BOSTON, MA and PROVIDENCE, RI, June 02, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS), today …
ConnectM Provides Update to Stockholders on Buyout Group’s Offer
GlobeNewswire
·
June 2, 2025
MARLBOROUGH, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a high-growth technology company on the leading edge of the modern energy economy, today issued an update to its …
4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment Responders in a Difficult-To-Treat Breast Cancer Patient Population
GlobeNewswire
·
June 2, 2025
NEWTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- 4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, unveiled groundbreaking findings at the American Society of Clinical Oncology (ASCO …
Precede Biosciences Presents ASCO 2025 Data Highlighting the Ability of its Liquid Biopsy Platform to Reveal the Biology Underlying Response and Resistance to ADCs and Radiopharmaceuticals
GlobeNewswire
·
June 2, 2025
Using just 1mL of plasma, the Precede Bio platform identified key molecular pathways linked to response and resistance in patients with metastatic breast and prostate cancer treated with sacituzumab govitecan and 177Lu-PSMA-617, respectively BOSTON, June …
Gordon Brothers Provides Linen Chest C$35M Revolving Credit Facility
GlobeNewswire
·
June 2, 2025
Boston, June 02, 2025 (GLOBE NEWSWIRE) -- Gordon Brothers, the global asset experts, has provided Linen Chest a C$35 million revolving credit facility to increase the Canadian home goods and accessories omni-channel retailer’s liquidity and support future …
Mimecast Partners with Zscaler to Mitigate Multi-Vector Cyber Threats
GlobeNewswire
·
June 2, 2025
LEXINGTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Mimecast, a global cybersecurity leader transforming the way businesses manage and secure human risk, today announced a new strategic integration with Zscaler™. Building on Mimecast’s extensive library of …
PathAI and Northwestern Medicine Announce Strategic Collaboration to Deploy the AISight® Digital Pathology Platform and Co-Develop New AI Diagnostics
GlobeNewswire
·
June 2, 2025
BOSTON and CHICAGO, June 02, 2025 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system, today announced a strategic collaboration to transform …
Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering
GlobeNewswire
·
June 2, 2025
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the pricing …
Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE …
Liberty Defense Commences Normal Course Issuer Bid to Buy Back Up-to 9.9% of the Publically Traded Float
GlobeNewswire
·
June 2, 2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. WILMINGTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE: E30), a leading …